Literature DB >> 22806573

Method for sampling tissue for research which preserves pathological data in radical prostatectomy.

Anne Y Warren1, Hayley C Whitaker, Beverley Haynes, Trogon Sangan, Leigh-Anne McDuffus, Jonathan D Kay, David E Neal.   

Abstract

BACKGROUND: The diagnosis and treatment of prostate cancer is a challenging global healthcare issue requiring significant molecular research. Such research frequently utilizes fresh frozen human tissue which needs to be obtained in a manner acceptable to the pathologist which does not compromise tumor diagnosis or staging.
METHODS: Radical prostatectomy specimens were handled in a standardized method before being sliced fresh. Leaving the margins intact, multiple cylindrical cores were removed using a large skin punch and the sites were marked on a prostate map. The cylindrical cores were placed onto individual, pre-numbered foil squares and snap frozen in liquid nitrogen. Prostate maps were aligned with formalin-fixed paraffin embedded hematoxylin and eosin stained sections of the sampled slice to select tumor regions. Frozen tumor tissue cylinders were processed taking one section for hematoxylin and eosin staining, 6 µm × 50 µm sections for molecular studies and a further section for hematoxylin and eosin staining. This was performed for the length of the cylinder.
RESULTS: A total of 150 prostates have been removed and sliced using this technique. Pathological assessment remained uncompromised. Using the sequential hematoxylin and eosin stained frozen sections, cellularity could be monitored closely in tissues processed for research. The yield of RNA and DNA extracted was high (tumor mean 2.4 µg (RNA) and 12.7 ng per 300 µm tissue) and of high quality (mean tumor RIN 5.9).
CONCLUSIONS: This novel, rapid sampling and processing method provides high quality tissue for research without compromising pathology.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22806573     DOI: 10.1002/pros.22556

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens.

Authors:  Tatjana Vlajnic; Martin Oeggerli; Cyrill Rentsch; Heike Püschel; Tobias Zellweger; George N Thalmann; Christian Ruiz; Lukas Bubendorf
Journal:  Virchows Arch       Date:  2014-10-17       Impact factor: 4.064

2.  Gene regulatory mechanisms underpinning prostate cancer susceptibility.

Authors:  Thomas Whitington; Ping Gao; Wei Song; Helen Ross-Adams; Alastair D Lamb; Yuehong Yang; Ilaria Svezia; Daniel Klevebring; Ian G Mills; Robert Karlsson; Silvia Halim; Mark J Dunning; Lars Egevad; Anne Y Warren; David E Neal; Henrik Grönberg; Johan Lindberg; Gong-Hong Wei; Fredrik Wiklund
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

3.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

4.  DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Authors:  Bogdan-Alexandru Luca; Daniel S Brewer; Dylan R Edwards; Sandra Edwards; Hayley C Whitaker; Sue Merson; Nening Dennis; Rosalin A Cooper; Steven Hazell; Anne Y Warren; Rosalind Eeles; Andy G Lynch; Helen Ross-Adams; Alastair D Lamb; David E Neal; Krishna Sethia; Robert D Mills; Richard Y Ball; Helen Curley; Jeremy Clark; Vincent Moulton; Colin S Cooper
Journal:  Eur Urol Focus       Date:  2017-03-06

5.  HES5 silencing is an early and recurrent change in prostate tumourigenesis.

Authors:  Charles E Massie; Inmaculada Spiteri; Helen Ross-Adams; Hayley Luxton; Jonathan Kay; Hayley C Whitaker; Mark J Dunning; Alastair D Lamb; Antonio Ramos-Montoya; Daniel S Brewer; Colin S Cooper; Rosalind Eeles; Anne Y Warren; Simon Tavaré; David E Neal; Andy G Lynch
Journal:  Endocr Relat Cancer       Date:  2015-01-05       Impact factor: 5.678

6.  Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Authors:  Colin S Cooper; Rosalind Eeles; David C Wedge; Peter Van Loo; Anne Y Warren; Christopher S Foster; Hayley C Whitaker; Ultan McDermott; Daniel S Brewer; David E Neal; Gunes Gundem; Ludmil B Alexandrov; Barbara Kremeyer; Adam Butler; Andrew G Lynch; Niedzica Camacho; Charlie E Massie; Jonathan Kay; Hayley J Luxton; Sandra Edwards; ZSofia Kote-Jarai; Nening Dennis; Sue Merson; Daniel Leongamornlert; Jorge Zamora; Cathy Corbishley; Sarah Thomas; Serena Nik-Zainal; Sarah O'Meara; Lucy Matthews; Jeremy Clark; Rachel Hurst; Richard Mithen; Robert G Bristow; Paul C Boutros; Michael Fraser; Susanna Cooke; Keiran Raine; David Jones; Andrew Menzies; Lucy Stebbings; Jon Hinton; Jon Teague; Stuart McLaren; Laura Mudie; Claire Hardy; Elizabeth Anderson; Olivia Joseph; Victoria Goody; Ben Robinson; Mark Maddison; Stephen Gamble; Christopher Greenman; Dan Berney; Steven Hazell; Naomi Livni; Cyril Fisher; Christopher Ogden; Pardeep Kumar; Alan Thompson; Christopher Woodhouse; David Nicol; Erik Mayer; Tim Dudderidge; Nimish C Shah; Vincent Gnanapragasam; Thierry Voet; Peter Campbell; Andrew Futreal; Douglas Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

7.  Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Authors:  Niedzica Camacho; Peter Van Loo; Sandra Edwards; Jonathan D Kay; Lucy Matthews; Kerstin Haase; Jeremy Clark; Nening Dennis; Sarah Thomas; Barbara Kremeyer; Jorge Zamora; Adam P Butler; Gunes Gundem; Sue Merson; Hayley Luxton; Steve Hawkins; Mohammed Ghori; Luke Marsden; Adam Lambert; Katalin Karaszi; Gill Pelvender; Charlie E Massie; Zsofia Kote-Jarai; Keiran Raine; David Jones; William J Howat; Steven Hazell; Naomi Livni; Cyril Fisher; Christopher Ogden; Pardeep Kumar; Alan Thompson; David Nicol; Erik Mayer; Tim Dudderidge; Yongwei Yu; Hongwei Zhang; Nimish C Shah; Vincent J Gnanapragasam; William Isaacs; Tapio Visakorpi; Freddie Hamdy; Dan Berney; Clare Verrill; Anne Y Warren; David C Wedge; Andrew G Lynch; Christopher S Foster; Yong Jie Lu; G Steven Bova; Hayley C Whitaker; Ultan McDermott; David E Neal; Rosalind Eeles; Colin S Cooper; Daniel S Brewer
Journal:  PLoS Genet       Date:  2017-09-25       Impact factor: 5.917

8.  Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.

Authors:  H Ross-Adams; A D Lamb; M J Dunning; S Halim; J Lindberg; C M Massie; L A Egevad; R Russell; A Ramos-Montoya; S L Vowler; N L Sharma; J Kay; H Whitaker; J Clark; R Hurst; V J Gnanapragasam; N C Shah; A Y Warren; C S Cooper; A G Lynch; R Stark; I G Mills; H Grönberg; D E Neal
Journal:  EBioMedicine       Date:  2015-07-29       Impact factor: 8.143

9.  The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.

Authors:  Greg L Shaw; Hayley Whitaker; Marie Corcoran; Mark J Dunning; Hayley Luxton; Jonathan Kay; Charlie E Massie; Jodi L Miller; Alastair D Lamb; Helen Ross-Adams; Roslin Russell; Adam W Nelson; Matthew D Eldridge; Andrew G Lynch; Antonio Ramos-Montoya; Ian G Mills; Angela E Taylor; Wiebke Arlt; Nimish Shah; Anne Y Warren; David E Neal
Journal:  Eur Urol       Date:  2015-11-10       Impact factor: 20.096

10.  Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy.

Authors:  Basetti Madhu; Greg L Shaw; Anne Y Warren; David E Neal; John R Griffiths
Journal:  Metabolomics       Date:  2016-06-30       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.